Filing identity and reporting period
Important identity discrepancy: The supplied filing is Heatwurx, Inc.’s Form 10-Q for the quarter ended March 31, 2015; it does not identify Processa Pharmaceuticals, Inc. The summary below reflects the filing text provided.
Heatwurx develops asphalt-repair equipment and technology, provides asphalt restoration services through Dr. Pave, and operates a franchise subsidiary. The company reported that no franchises had been sold as of the filing.
Financial results and liquidity
| Metric | Q1 2015 | Q1 2014 / comparison |
|---|---|---|
| Revenue | $46,590 | $20,435 |
| Gross profit / margin | $17,321 / 37.2% | $11,205 / 54.8% |
| Operating expenses | $616,343 | $1,295,432 |
| Operating loss | $599,022 | $1,284,227 |
| Net loss | $644,606 | $1,344,276 |
| Net loss per common share | $0.06 | $0.17 |
| Cash used in operations | $502,088 | $987,738 |
Revenue comprised equipment sales of $32,760, service revenue of $8,830, and other revenue of $5,000. The filing reports no operating cash flow benefit sufficient to offset the company’s substantial operating costs.
At March 31, 2015, cash was $41,783; current assets were $497,152 and current liabilities were $1,721,784, implying negative working capital of approximately $1.22 million. Total liabilities were $1,841,230, versus stockholders’ equity of $701,790. Current liabilities included $630,000 of senior secured notes, a $229,980 revolving credit line, and $374,731 of unsecured notes, net of discount. The filing also reports $119,446 of long-term equipment loans.
Cash increased by $20,549 during the quarter, as $524,036 of financing cash inflows—principally $450,000 of senior secured note proceeds and $88,000 of stock proceeds—exceeded operating and investing cash use. The company reported approximately $220,000 in monthly spending.
Material changes versus the prior-year quarter
- Revenue more than doubled, mainly because of higher equipment sales; service revenue declined.
- Gross margin fell to 37.2% from 54.8%, as cost of goods sold increased faster than revenue.
- Net loss narrowed by about $700,000. Lower SG&A and research and development costs contributed; the prior-year quarter also included a $390,659 goodwill impairment that did not recur.
- Operating cash use improved by about $486,000, though it remained substantial.
- Cash was $41,783 at quarter-end, compared with $21,234 at December 31, 2014; secured debt and total liabilities increased.
Outlook, risks, and unusual items
Management stated that cash on hand was inadequate for the next twelve months and that the company expected to need at least $2.6 million to meet cash-flow requirements over that period. The filing states that these conditions raise substantial doubt about the company’s ability to continue as a going concern; continued operations depend on obtaining additional financing and growing revenue. No assurance was given that financing would be available or that operations would become profitable.
The company entered a senior secured loan facility of up to $2 million at 12% interest, with notes generally maturing six months after issuance and secured by all company assets, including intellectual property. Management said it did not expect to meet mandatory 2015 principal payments and would seek extensions or conversion options. A default could permit lenders to foreclose on company assets. The filing reports $470,000 of principal issued under the facility during Q1 and a further $179,000 issued after quarter-end; it also says the company received aggregate cash of $629,000 by May 14, 2015. The relationship between those reported amounts is not fully clear from the filing text.
Other risks include dependence on a small group of investors, limited revenue since inception, competition and regulatory or operating risks in the asphalt-repair industry, and ineffective disclosure controls due to a material weakness involving insufficient accounting personnel. Management planned remediation during 2015 and anticipated resolving the weakness by December 31, 2015. The company also disclosed that it had become a voluntary SEC filer after having fewer than 300 record holders at the start of 2015 and could stop filing reports without notice.
Subsequent events included the CEO’s April 30, 2015 resignation; the interim CFO also became interim CEO while a search was conducted. The company reported $629,000 in aggregate cash receipts by May 14 and additional secured borrowing as noted above.
Key facts for investors to verify
- Confirm the issuer: the supplied document is for Heatwurx, Inc., not Processa Pharmaceuticals, Inc.
- Verify available cash, subsequent financing proceeds, and the company’s actual near-term funding needs.
- Reconcile secured-note amounts, 2015 maturities, and the filing’s disclosures about post-quarter borrowing and cash received.
- Assess whether lenders will extend or convert debt and the consequences of default on collateral, including intellectual property.
- Review progress on revenue growth, franchise sales, going-concern risk, and remediation of the material weakness in financial reporting controls.